BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16278148)

  • 1. Binding of circulating SLE autoantibodies to oxygen free radical damaged chromatin.
    Mansoor F; Ali A; Ali R
    Autoimmunity; 2005 Sep; 38(6):431-8. PubMed ID: 16278148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of SLE autoantibodies to native poly(I), ROS-poly(I) and native DNA: a comparative study.
    Tasneem S; Ali R
    J Autoimmun; 2001 Nov; 17(3):199-205. PubMed ID: 11712857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive oxygen species modified polyguanylic acid: immunogenicity and implications for systemic autoimmunity.
    Garg DK; Ali R
    J Autoimmun; 1998 Aug; 11(4):371-8. PubMed ID: 9776715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding characteristics of SLE anti-DNA autoantibodies to Catecholestrogen-modified DNA.
    Khan WA
    Scand J Immunol; 2006 Dec; 64(6):677-83. PubMed ID: 17083625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of chromatin modified with reactive oxygen species: recognition by autoantibodies in cancer.
    Mansoor F; Ali R
    Clin Biochem; 2007 Sep; 40(13-14):928-35. PubMed ID: 17628516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of singlet oxygen modified human DNA: implications for anti-DNA antibodies in systemic lupus erythematosus.
    Al Arfaj AS; Chowdhary AR; Khalil N; Ali R
    Clin Immunol; 2007 Jul; 124(1):83-9. PubMed ID: 17540620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of mitochondrial DNA modified by hydroxyl radical.
    Alam K; Moinuddin ; Jabeen S
    Cell Immunol; 2007 May; 247(1):12-7. PubMed ID: 17716639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced recognition of reactive oxygen species damaged human serum albumin by circulating systemic lupus erythematosus autoantibodies.
    Rasheed Z; Ahmad R; Rasheed N; Ali R
    Autoimmunity; 2007 Nov; 40(7):512-20. PubMed ID: 17966041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lupus erythematosus cell phenomenon: comparative analysis of antichromatin antibody specificity in lupus erythematosus cell-positive and -negative sera.
    Schett G; Rubin RL; Steiner G; Hiesberger H; Muller S; Smolen J
    Arthritis Rheum; 2000 Feb; 43(2):420-8. PubMed ID: 10693884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced recognition of hydroxyl radical modified plasmid DNA by circulating cancer antibodies.
    Khan F; Ali A; Ali R
    J Exp Clin Cancer Res; 2005 Jun; 24(2):289-96. PubMed ID: 16110763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement and significance of 3-nitrotyrosine in systemic lupus erythematosus.
    Khan F; Siddiqui AA; Ali R
    Scand J Immunol; 2006 Nov; 64(5):507-14. PubMed ID: 17032243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosus.
    Lefkowith JB; Kiehl M; Rubenstein J; DiValerio R; Bernstein K; Kahl L; Rubin RL; Gourley M
    J Clin Invest; 1996 Sep; 98(6):1373-80. PubMed ID: 8823302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxyl radical modification of human serum albumin generated cross reactive antibodies.
    Rasheed Z; Khan MW; Ali R
    Autoimmunity; 2006 Sep; 39(6):479-88. PubMed ID: 17060027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactive oxygen species damaged human serum albumin in patients with type 1 diabetes mellitus: biochemical and immunological studies.
    Rasheed Z; Ali R
    Life Sci; 2006 Nov; 79(24):2320-8. PubMed ID: 16945391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catecholoestrogens: possible role in systemic lupus erythematosus.
    Khan WA; Uddin M; Khan MW; Chabbra HS
    Rheumatology (Oxford); 2009 Nov; 48(11):1345-51. PubMed ID: 19651882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
    Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
    Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus.
    Bardin N; Desplat-Jego S; Daniel L; Jourde Chiche N; Sanmarco M
    Autoimmunity; 2009 Jan; 42(1):63-8. PubMed ID: 19127456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lupus-derived monoclonal autoantibodies against apoptotic chromatin recognize acetylated conformational epitopes.
    van Bavel CC; Dieker JW; Tamboer WP; van der Vlag J; Berden JH
    Mol Immunol; 2010; 48(1-3):248-56. PubMed ID: 20817300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients.
    Tsacheva I; Radanova M; Todorova N; Argirova T; Kishore U
    Mol Immunol; 2007 Mar; 44(8):2147-51. PubMed ID: 17049989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.